Intrexon Organizes Around New Synthetic Biology Markets

Nine Collaborations Underway, Company Aligns to Accelerate Business 
Development in Health, Food, Energy and Environment 
GERMANTOWN, Md., May 9, 2013 /CNW/ - Intrexon Corporation, a leader in 
synthetic biology that is helping companies design and develop products 
incorporating its Better DNA™, today announced it has aligned its industry 
markets to focus on four key sectors: Health, Food, Energy and Environment. 
Intrexon currently has nine collaborations in Health and Food to create 
products embodying engineered bio-based solutions.  The goal of the new market 
alignment is to accelerate business development across all of Intrexon's key 
market sectors using the company's Exclusive Channel Collaboration (ECC) model. 
Since Intrexon's founding in 1998 the company has developed its core 
technology, the UltraVector® platform, to accelerate development of 
genetically-enhanced products at industrial scale.  Using a dynamic library of 
more than two million diverse, modular genetic components, UltraVector enables 
the discovery, design, assembly and testing of a wide spectrum of multigenic 
biological systems. 
As part of its new market strategy, Intrexon named the following executives 
with deep industry experience to lead each market sector: 


    --  Health will be led by Dr. Samuel Broder, Executive Director of
        the Intrexon Institute for Biomolecular Research and former
        Director of the National Cancer Institute.
    --  Food will be led by Dr. Thomas Kasser, with more than
        twenty-five years of senior management experience in
        agricultural biotechnology and animal health and nutrition,
        recognized as a Monsanto Fellow for his scientific and
        technical excellence.
    --  Energy will be led by Robert Walsh, with over 30 years of
        global petroleum and chemical industry experience, including 26
        years at Royal Dutch Shell.
    --  Environment will be led by Nick Macris, with 15 years in the
        specialty chemical, water treatment, agricultural chemical and
        biopesticide industries with many large and small companies
        including 3M, Rohm and Haas, and FMC Corporation

Chairman and Chief Executive Officer Randal J. Kirk said the new market 
alignment will help Intrexon achieve its vision to be one of the leading life 
science companies in the world.

"Our new sector organization, led by an outstanding team of industry veterans, 
will bring additional focus and rapidity to solving our partners' toughest 
synthetic biology problems," Kirk said.  "It's a very exciting step toward 
empowering the bioindustrial revolution with solutions that enhance the 
quality and diversity of life."

About Intrexon Corporation

Intrexon Corporation is a privately held biotechnology company focused on 
collaborating with companies in Health, Food, Energy and the Environment to 
create bio-based products that improve the quality of life and the health of 
the planet.  Through the company's proprietary UltraVector® platform, 
Intrexon provides its partners with industrial-scale design and development of 
multigenic biology.  UltraVector delivers unprecedented control over the 
quality, reliability, and performance of living cells.  We call it Better 
DNA™ and we invite you to discover more at www.dna.com.

Trademarks

Intrexon, UltraVector, mAbLogix and Better DNA are trademarks of Intrexon 
and/or its affiliates.  Other names may be trademarks of their respective 
owners.

Safe Harbor Statement

Some of the statements made in this press release are forward-looking 
statements.  These forward-looking statements are based upon our current 
expectations and projections about future events and generally relate to our 
plans, objectives and expectations for the development of our business.  
Although management believes that the plans and objectives reflected in or 
suggested by these forward-looking statements are reasonable, all 
forward-looking statements involve risks and uncertainties and actual future 
results may be materially different from the plans, objectives and 
expectations expressed in this press release.

For more information regarding Intrexon Corporation, contact:

Corporate Contact:                                                                             Investor Contact:

Marie L. Rossi, Ph.D.                                                                          The Ruth Group

Manager, Technical Communications                                                              Stephanie Carrington / 
Melanie Sollid-Penton

Intrexon Corporation                                                                           Tel: +1 646-536-
7017/7009

Tel: +1 301-556-9944                                                                           
scarrington@theruthgroup.com

mrossi@intrexon.com  msollid@theruthgroup.com

http://www.dna.com

SOURCE: Intrexon Corporation

To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/May2013/09/c5460.html

CO: Intrexon Corporation
ST: Maryland
NI: HEA MTC BTC 

-0- May/09/2013 18:39 GMT


 
Press spacebar to pause and continue. Press esc to stop.